Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Glimmers in illuminating the druggable genome

Nature Reviews Drug Discovery volume 17, pages 301–302 (2018)Cite this article

Subjects

Much biomedical research continues to focus on a small proportion of the human genome that has already been studied intensively. The Illuminating the Druggable Genome programme, initiated as a pilot project by the US National Institutes of Health Common Fund in 2014, is now being implemented to accelerate the investigation of subsets of understudied proteins that have potential therapeutic relevance.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Santos, R. et al. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16, 19–34 (2017).

    Article  CAS  Google Scholar 

  2. Edwards, A. M. et al. Too many roads not taken. Nature 470, 163–165 (2011).

    Article  CAS  Google Scholar 

  3. Nguyen, D. T. et al. Collating protein information to shed light on the druggable genome. Nucleic Acids Res. 45, D995–D1002 (2017).

    Article  CAS  Google Scholar 

  4. Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362–369 (2015).

    Article  CAS  Google Scholar 

  5. Bruni, G. et al. Zebrafish behavioral profiling identifies multi-target antipsychotic-like compounds. Nat. Chem. Biol. 12, 559–566 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Office of the Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, 20892, Maryland, USA

    Griffin Rodgers

  2. Office of the Director, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, 20817, Maryland, USA

    Christopher Austin & Christine Colvis

  3. Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health, Bethesda, 20892, Maryland, USA

    James Anderson

  4. Division of Diabetes, Endocrinology, and Metabolic Diseases. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, 20892, Maryland, USA

    Aaron Pawlyk, Ronald Margolis & Jenna Baker

Authors
  1. Griffin Rodgers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Austin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aaron Pawlyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christine Colvis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ronald Margolis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jenna Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aaron Pawlyk.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

FURTHER INFORMATION

GEN

Illuminating the Druggable Genome programme

NIH Common Fund

Pharos

Unexplored opportunities in the druggable human genome

Illuminating the Druggable Genome programme homepage

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodgers, G., Austin, C., Anderson, J. et al. Glimmers in illuminating the druggable genome. Nat Rev Drug Discov 17, 301–302 (2018). https://doi.org/10.1038/nrd.2017.252

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2017.252

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research